EP Patent

EP0444659A2 — A pharmaceutical solution comprising derivatives of FK506

Assigned to Astellas Pharma Inc · Expires 1991-09-04 · 35y expired

What this patent protects

A pharmaceutical solution which contains the compound of the general formula having the immusuppreseive activity is disclosed. <CHEM> n

USPTO Abstract

A pharmaceutical solution which contains the compound of the general formula having the immusuppreseive activity is disclosed. <CHEM> n

Drugs covered by this patent

Patent Metadata

Patent number
EP0444659A2
Jurisdiction
EP
Classification
—
Expires
1991-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Astellas Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.